Abstract Activation of inflammatory pathways is one plausible mechanism underlying the association between obesity and increased breast cancer risk. However, macrophage infiltration and local biomarkers of inflammation in breast adipose tissue have seldom been studied in association with obesity. Gene expression profiles of normal breast tissue from reduction mammoplasty patients were evaluated by whole genome microarrays to identify patterns associated with obesity status (normal-weight, body mass index (BMI) \25; overweight, BMI 25-29.9; obese, BMI C30). The presence of macrophage-enriched inflammatory loci with immunopositivity for CD68 protein was evaluated by immunohistochemistry (IHC). After adjusting for confounding by age, 760 genes were differentially expressed (203 up and 557 down; FDR = 0.026) between normalweight and obese women. Gene ontology analysis suggested significant enrichment for pathways involving IL-6, IL-8, CCR5 signaling in macrophages and RXRa and PPARa activation, consistent with a pro-inflammatory state and suggestive of macrophage infiltration. Gene set enrichment analysis also demonstrated that the genomic signatures of monocytes and macrophages were over-represented in the obese group with FDR of 0.08 and 0.13, respectively. Increased macrophage infiltration was confirmed by IHC, which showed that the breast adipose tissue of obese women had higher average macrophage counts (mean = 8.96 vs. 3.56 in normal-weight women) and inflammatory foci counts (mean = 4.91 vs. 2.67 in normal-weight women). Obesity is associated with local inflammation and macrophage infiltration in normal human breast adipose tissues. Given the role of macrophages in carcinogenesis, these findings have important implications for breast cancer etiology and progression.
Introduction
In past decades, the relationship between obesity and breast cancer risk has been extensively studied. It has been established that obesity is strongly associated with a higher risk of postmenopausal breast cancer, with a 12% increase in risk per 5 kg/m 2 increase in body mass index (BMI) [1] [2] [3] . Recent research has suggested that obesity may also be associated with premenopausal breast cancer [4] . In the largest study based on pooled data from 35,568 invasive breast cancer cases, Yang et al. [5] found that obesity was associated with increased risk of estrogen receptor negative/progesterone receptor negative (ER-/PR-) tumors with an even stronger relation with triple-negative or basallike tumors among younger women (B50 years). Thus, while the relationships between obesity and breast cancer risk are complex, there is growing evidence to support an etiologic role for obesity in multiple types of breast cancer, both premenopause and postmenopause. These epidemiologic findings underscore the importance of research on obesity-associated breast cancer risk and its underlying biological mechanisms.
Obesity is characterized by expanded adipose tissue, which is traditionally considered as the physiological site of energy storage. However, adipose tissue is also recognized as an endocrine organ actively participating in numerous physiological processes [6, 7] . The biological basis for obesity-associated breast cancer risk is not well established, though several mechanisms have been postulated including dysregulated steroid hormone levels or response, insulin resistance, insulin-like growth factor pathways, and adipokines [8] [9] [10] [11] . It is clear that obesity results in impaired adipose tissue function, ultimately, increasing production and secretion of inflammatory molecules, like tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), and monocyte chemotactic protein-1(MCP-1) [12, 13] . These molecules have both local and systemic inflammation effects [1, 7] .
While systemic effects have been a major focus of obesity-biomarker research, local effects on breast cancer microenvironment are also important to consider. Locally, cancer-related inflammation is characterized by inflammatory cell infiltration, increased levels of inflammatory cytokines, and tissue remodeling, together mimicking biological processes present during wound response [14, 15] . Sustained local inflammation attenuates cell-mediated immunity and increases angiogenesis, providing an ideal microenvironment for cancer development and progression [16, 17] . Thus, the there is support for the hypothesis that chronic local inflammation induced by obesity may predispose individuals to breast cancer or may alter the progression of disease. However, the presence of inflammatory biomarkers and the presence of specific inflammatory cell types in breast tissue has received limited investigation. Most often, when breast tissue is studied, it is tissue of women with disease (invasive breast cancer, ductal carcinoma in situ, or benign breast disease). To evaluate the hypothesis that obesity increases local inflammation and creates an ideal microenvironment for cancer promotion and progression, we evaluate gene expression profiles and performed immunohistochemical (IHC) analysis of the normal breast tissue from reduction mammoplasty patients. Our findings demonstrate that in women without disease, obesity is associated with local changes in gene expression and cellular composition.
Materials and methods

Study population
Study subjects were women undergoing reduction mammoplasty at Baystate Medical Center in Springfield, Massachusetts between 2007 and 2010. The Institutional Review Boards at Baystate Medical Center and University of Massachusetts Amherst approved the study. All participants consented to provide excess tissues not needed for diagnostic purposes. Tissues were handled by snap freezing immediately after surgery and stored at -80°C. Specimens were excluded if pathologic assessment of patient-matched, paraffin-embedded tissues suggested any abnormal malignant or premalignant findings. Demographic and reproductive information were collected by a telephone interview administered following surgery. Patients in the current investigation include those with complete data on BMI, available fresh frozen tissues to perform microarray, and paraffin blocks for IHC.
RNA isolation and microarrays
All microarrays were performed at the University of North Carolina at Chapel Hill. Frozen specimens were cut over dry ice and then homogenized (approximately 100 mg per whole tissue specimen was homogenized for nucleic acid isolation). RNA was isolated following standard manufacturer protocols using RNeasy kits. Higher RNA yields were obtained with fatty, reduction mammoplasty tissues when using a Qiazol extraction step (Qiagen) prior to purification on RNeasy column as described in Troester et al. [18] . RNA quality and quantity were analyzed on an Agilent 2100 Bioanalyzer and a ND-1000 Nanodrop spectrophotometer, respectively, before running two-color 4944 K Agilent whole genome arrays. Cy3-labeled reference was produced from total RNA from Stratagene Universal Human Reference (spiked with 1:1000 with MCF-7 RNA and 1:1000 with ME16C RNA to increase expression of breast cancer genes) following amplification with Agilent low RNA input amplification kit with minor modifications as described in Hu et al. [19] . The identical protocol was applied to total RNA from reduction mammoplasty specimens, with all patient samples labeled with Cy5. Data were Lowess-normalized and probes that had a signal of \10 dpi in either channel were excluded as missing, and probes that had more than 20% missing data across all samples were excluded from further analysis. After mapping the ENTREZ ID based on manufacturer ID using Bioconductor libraries (hgug4112a.db: hgug4112a ENTREZID) [20, 21] , we (a) eliminated the probes without corresponding ENTREZ ID, (b) took the average of the duplicate probes, and (c) imputed missing data using k-nearest neighbors (KNN) method with k = 10. To focus on genes with variable expression, we further excluded the probes with interquartile range (IQR) \ median IQR. After the above preprocessing, the number of the genes in the analysis was 8,280. All data are publicly available through the Gene Expression Omnibus (GSE16113 and GSE pending).
Gene expression data analysis
All of the following data analyses were performed using R (version 2.9.2). Obese status of the study subjects was categorized into three groups based on BMI using current Center for Disease Control (CDC) and World Health Organization (WHO) definitions: obese was defined as BMI C30 kg/m 2 , overweight was defined as 25 kg/ m 2 B BMI \ 30 kg/m 2 , and normal-weight was defined as BMI \25 kg/m 2 . No patients in this study had BMI \20 kg/m 2 . The distribution of the selected characteristics of the study subjects by obese status was evaluated using Fisher's exact test, with significant association defined using a two-sided a of 0.05. Covariates that were associated with both obesity (P B 0.05) and differential gene expression (false-discovery rate (FDR) B0.05) were considered as potential confounders and further included in the model selection. Considering the sample size, a forward selection strategy and partial F test were used to refine the model [22] . Potential confounders were added into the model with gene expression level as the dependent variable and obese status as the independent variable. The covariate was retained in the ANOVA model if it was associated with differentially expressed genes in the presence of obesity. FDR was used to control type I error due to multiple testing.
The biological function and network of the significant genes were assessed using Ingenuity Systems Pathway analysis (IPA) (Ingenuity Ò Systems, http://www.ingenuity. com). To confirm the pathways or functions suggested by IPA, Gene Set Enrichment Analysis (GSEA version 3.5) was performed. The genomic profiles of human peripheral monocytes [23] and human abdominal adipose tissue macrophages [24] were evaluated by GSEA, including all the genes in each of these published lists that mapped to data from the reduction mammoplasty specimens on 4944 K Agilent microarrays. Phenotype permutation (normal-weight vs. obese) and FDR were used to assess multiple testing [25] with FDR \0.25 considered statistically significant [26] .
Macrophage infiltration
Immunohistochemistry was used to evaluate macrophage infiltration. In brief, formalin-fixed, paraffin-embedded tissues were sectioned at 7 lm and stained with antibody to CD68 (abcam, ab955, diluted 1:200) with diaminobenzidine. CD68 staining was revealed through the use of a biotinylated secondary (Jackson ImmunoResearch 115-065-166), ABC complex (Standard Elite Vector Laboratories, PK6100) and reacted in diaminobenzidine (Invitrogen DAB Substrate Kit 00-2014). CD68 positive cells were quantitated in adipose tissue, with macrophage infiltration measured by the average count of CD68 positive cells in three randomly selected 109 fields per patient, and inflammatory foci measured as total number per slide of aggregations of CD68 positive cells (CD68 positive cells C5).
Results
Characteristics of the study population
As is typical for women undergoing reduction mammoplasty, patients in our study tended to be more obese than general US population [27] . In this study, 22, 38, and 40% of the 74 women were normal-weight, overweight, and obese, respectively. Table 1 shows the population characteristics according to obesity status. The women in the higher categories of obesity status were more likely to be older, postmenopausal, past oral contraceptive users, and past smokers (P B 0.05 in all instances). We did not observe significant differences in race/ethnicity, parity, breastfeeding, and first-degree family history of breast cancer by obesity status. Age, menopausal status, smoking, and oral contraceptive use were considered as potential confounders of the obesity-gene expression association. However, further analysis indicated that only age showed a significant effect (FDR B 0.05) on the gene expression when obesity status was already in the model. Therefore, the final ANOVA model for obesity-associated gene expression included only age and obesity status.
Differentially expressed genes by obese status
Using the microarray data from 74 reduction mammoplasty samples with gene expression levels as outcome/dependent variables, we performed ANOVAs to identify genes that were differentially expressed by obesity status with normalweight women as the reference category. After controlling for age, a genomic profile of 760 genes that was differentially expressed between obese group and normalweight group (FDR \ 0.026) was identified, with 203 genes up-regulated and 557 down-regulated (Supplementary Table 1 ). Figure 1a demonstrates that the 760 gene signature produced a distinct difference between normal-weight and obese women using a one-way (genes only) cluster of these genes with the 74 patients ordered by BMI. Interestingly, this figure shows there was relative homogeneity within the categories of BMI C30 kg/m 2 and BMI \25 kg/m 2 , but substantial heterogeneity existed among those in the overweight group (25 kg/m 2 B BMI \ 30 kg/m 2 ). By two-way (genes and samples) hierarchical clustering of the detected signature (Fig. 1b) , the study subjects were divided into three clusters. One cluster was very small including seven women who were similar to the rest of the study population (including the distribution of obesity status) with the exception of including more minorities (P = 0.08). In the remaining two clusters, one was enriched for normal-weight women (86% of normal-weight women were together in this cluster), and the other was enriched for obese women (78% of obese women were in this cluster). Overweight women were evenly distributed across the two clusters with about half in the normal-weight-enriched cluster (44%) and about half in the obese-enriched cluster (56%). Chi-square P value for distribution of overweight among normal-weight or obese clusters was 0.30. Thus, both one-dimensional (genes only) and two-dimensional (genes and samples) clusterings are suggestive of distinct BMI-associated gene expression effects between normal-weight and obese groups and an intermediate phenotype in overweight women. To evaluate whether there was a dose-response relationship between BMI and expression of the obesity-associated gene expression profile, the 64 patients from the two main clusters (normal-weight-enriched and obese-enriched clusters) were shown in Fig. 1c Ingenuity Systems Pathway Analysis was used to analyze for biological enrichment of specific pathways in the obesity-associated genomic signature detected by two-way ANOVA. As shown in Table 2 , the up-regulated genes in the 760 gene signature suggested association with endocrine system disorders and metabolic diseases including diabetes mellitus, metabolic syndrome X, non-alcoholic fatty liver, and dyslipidemia (Supplementary Table 2 ). Given the close associations between these diseases/disorders and obesity, the findings preliminarily indicated that changes in endocrine and metabolism induced by obesity may be reflected locally in the breast tissues. Interestingly, the up-regulated genes were also related to reproductive system diseases, particularly mammary carcinoma (Supplementary Table 2 ). The 760 gene signature also suggested enrichment for many canonical pathways. Among them, IL-6 and IL-8 signaling, PPARa/RXRa activation, and CCR5 [CD195, a receptor for RANTES and macrophage inflammatory protein (MIP)] signaling in macrophages were up-regulated. All of these pathways have plausible links to infiltration and/or action of macrophages, and considering the well-established association between obesity and infiltration of macrophages in human abdominal adipose tissues [12, 13] , we hypothesized that breast tissue in obese women would show changes in cellular composition, especially influx of macrophages.
Infiltration of macrophages
To evaluate the hypothesis that macrophages accumulate in the breast adipose tissues of obese women, we first took advantages of our gene expression data and performed GSEA analysis using published gene expression profiles of human peripheral monocytes [23] and human abdominal adipose tissue macrophages [24] , respectively (see Supplementary Table 3 for gene list). Compared to normalweight women, the monocyte genomic profile signature was enriched among obese women with a normalized enrichment score of 1.39 and FDR of 0.08. Likewise, the abdominal adipose macrophage genomic profile was also enriched with a normalized enrichment score of 1.42 and FDR of 0.13 ( Supplementary Fig. 1 ). These analyses show that monocyte/macrophage-associated genomic signatures are over-represented in the adipose tissue of obese women relative to normal-weight women.
More direct evidence of changes in composition comes from imaging studies of the human tissues. Thus, to 
Discussion
The human breast is a unique organ in that adipose tissue is a majority component, comprising up to 56% of the total breast volume [28] . Therefore, adipose tissue plays a critical role in regulating the microenvironment of breast tissue. However, the dynamics of the gene expression and cellular composition of breast tissue in response to various exposures and stimuli are not well studied. Adipose tissue is not only a passive reservoir for energy storage, but also a metabolic and endocrine organ, secreting numerous bioactive substrates termed adipokines, such as leptin, adiponectin, and resistin, as well as cytokines which act on the local breast microenvironment and systemically [12, 29] . Adipose tissue also harbors macrophages that maintain a balance in the production of pro-and anti-inflammatory adipocytokines [30] [31] [32] , which can be disrupted in obesity to create a chronic low-grade inflammatory state [33] . While tissue studies in animals have shown that inhibition of macrophage infiltration into obese adipose tissue can ameliorate the dysregulation of adipocytokine production, and further ameliorate adipose tissue inflammation and insulin resistance [34, 35] , most evidence in humans regarding this pathological process are based on the studies of abdominal/visceral adipose tissue [36] . In this study, we found evidence that this process may occur in non-malignant breast tissue. Many of the processes identified in our gene expression profile are representative well-established pathological conditions known to increase with obesity, however, we also identified specific pathways that are known to play an important role in breast microenvironment (e.g., IL-6) and that have been previously been described as systemic effects of obesity [6, 36] . The origin of the IL-6 signaling in our study may be from a variety of stromal sources, but previous studies have suggested that in adipose tissue, nonadipose stroma are the most likely contributors [36] . In our IHC analyses, macrophages are a likely contributor [37] . The identification of other interleukin signaling pathways as co-expressed (CCR5 and PPARa) also suggests a role for macrophages. The implications of this shift in the microenvironment milieu are compelling, particularly given research emphasizing the importance of IL-6 and IL-8 in maintaining a stem cell-like population in the breast [38] . Other pathways associated with mammary stem/progenitor cells and mammary gland development [39] [40] [41] , such as Wnt/b-catenin and RANK signaling pathways were also implicated in the gene expression patterns. In Ojalvo et al. [42] and Lau et al. [43] , these pathways are expressed in differentiating tumor-associated macrophages (TAMs), so tissue-level imaging of pathway specific markers will be needed to identify the source of these signals in normal breast tissue. Thus, further research regarding how macrophages and premalignant/malignant breast epithelium communicate in relation to breast cancer progression could provide important mechanistic insight for obesity-associated breast cancer.
Our sample size (n = 74) was similar to that for other observational microarray-based studies [44] and represents the largest reported study of reduction mammoplasty gene expression, but we nonetheless had limited power to detect differences in certain gene expression levels between BMIdefined groups. To offset concerns about the sample size, findings presented here were strengthened by combining gene expression data with histological features and more focused analyses of specific gene sets. Observations of inflammation and macrophage infiltration (detected in gene-by-gene significance analysis and ontology/pathway analysis) were supported by testing specific hypotheses based on the most relevant papers by using pathway analysis using GSEA and by performing an IHC validation study. The consistency of the results of various analyses using multiple techniques and approaches strengthens our inference and decreases the emphasis on individual genebased statistical hypothesis tests. While the variance and small sample size for the histological analyses resulted in P values of 0.05 and 0.07, the association was strong and is supportive of the statistically significant associations we observed by microarray. As per Poole [45] , selecting associations based on P values is not a strong basis for scientific inference. Poole notes that ''results that deserve the greatest reliance are those that are most stable and trustworthy.'' The stability of our results are supported by technically independent but biologically consistent results. Future studies should evaluate inflammation markers in independent test sets, preferably with large numbers of reduction mammoplasty patients.
Our analytical approaches are a strength of this study. While there are few established methods for addressing confounding in observational microarray studies [46, 47] , we used multivariable models to assess this important source of bias. Interestingly, age emerged as an important variable determining the gene expression. Age-associated effects on gene expression have been well recognized in animal tissues [48, 49] ; but further study in human breast tissue merits investigation. We also examined interaction (data not shown), and found limited evidence for effect modification by the factors we examined. For example, the gene expression did not vary substantially by menopausal status, hence pre-and postmenopausal women were grouped together. With larger sample sizes, it may be possible to evaluate additional interactions between obesity and menopausal status or reproductive history, which could help to elucidate which additional mechanisms have dominance during different windows of susceptibility.
Our study focused on reduction mammoplasty patients, which tend to have higher BMI than the general population. Nevertheless, there were also women with quite low BMI in our sample. In addition, the women in this study showed distributions of parity status and menopausal status not dissimilar to these of the general population. Thus, while reduction mammoplasty patients may not represent all women in the population (e.g., women with BMI \20 kg/m 2 or with very small breasts), the data here are still biologically relevant for a large subset of the general population. Furthermore, results presented here are consistent with recent studies focused on mice and breast cancer patients [50, 51] . Subbaramaiah et al. [51] observed crown-like structures (CLS) (similar structure as inflammation foci), and observed increased NF-jB binding activity and elevated aromatase expression and activity in breast tissues of obese mice. Morris et al. [50] showed that 75% of obese and 70% of overweight breast cancer patients had CLS, while among normal-weight breast cancer patients only 8.3% had CLS. This corresponds to an approximately nine-fold change in CLS comparing obese patients to normal-weight patients. In our study of women without breast cancer, we also observed a large fold-change in the proportion of patients with high macrophage infiltration and inflammatory foci comparing obese and normal-weight women (high macrophage infiltration more than four-fold and inflammatory foci more than two-fold more prevalent in obese compared to normal-weight women). Thus, the association we observed confirms the trends reported previously for associations between obesity and inflammatory foci/CLS. Whether inflammatory foci in turn confer greater risk of cancer merits investigation in a larger study. However, based on our data and the previous literature, the prevalence of macrophage foci in obese cancer patients (75%) is 1.25 times that among obese nondiseased (60% among obese reduction mammoplasty patients), which implies possible associations between macrophage infiltration and cancer outcome among obese and overweight women. Importantly, our data show that macrophage infiltration in adipose tissue precedes disease and is present in normal women with no pathological findings.
While the role of macrophage infiltration in breast cancer etiology is not established, the role of macrophage infiltration in breast cancer progression has been more widely studied. It is believed that macrophage infiltration promotes of angiogenesis, matrix remodeling, and suppression of adaptive immunity [52] . The TAM express several characteristics of M2-polarized macrophages [53] , while obesity is believed to induce a phenotypic switch in macrophages from an anti-inflammatory M2 polarized state to a pro-inflammatory M1 state, with the M1 macrophages composing the ''CLS'' surrounding adipocytes [54, 55] . Thus, based on biological dynamics during disease progression, a possible model for the role of macrophages in etiology is that chronic inflammation caused by obesity (with microphage in M1 state) causes DNA damage, such as oncogene activation or tumor-suppressor genes inactivation. Alternatively, the presence of macrophage in the obese microenvironment from the earliest stages of tumor onset may lead to promotion of very early cancers through specific signaling mechanisms, including elevated expression of NF-jB and increased aromatase activity as recently reported [50] . Further studies should evaluate the specific M1 and M2 markers that may help delineate more subtle population shifts among the mixed population of CD68 cells. A recent study suggests that proliferation markers in combination with CD68 staining may also have prognostic value [56] . Thus, a wide range of markers for macrophage dynamic and inflammatory effects in normal tissue may provide new insight into the etiology and progression of breast cancer. Each of these markers should be evaluated in light of the heterogeneity of breast cancer, preferably by both menopausal status and by estrogen receptor status. Further research on the tissue composition and gene expression behavior of normal breast tissue in relation to breast cancer could identify important etiologic pathways underlying the association between obesity and breast cancer.
